Cargando…
Hope and challenge: Precision medicine in bladder cancer
Bladder cancer (BC) is a complex disease and could be classified into nonmuscle‐invasive BC (NMIBC) or muscle‐invasive BC (MIBC) subtypes according to the distinct genetic background and clinical prognosis. Until now, the golden standard and confirmed diagnosis of BC is cystoscopy and the major prob...
Autores principales: | Su, Hongwei, Jiang, Haitao, Tao, Tao, Kang, Xing, Zhang, Xu, Kang, Danyue, Li, Shucheng, Li, Chengxi, Wang, Haifeng, Yang, Zhao, Zhang, Jinku, Li, Chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488142/ https://www.ncbi.nlm.nih.gov/pubmed/30907072 http://dx.doi.org/10.1002/cam4.1979 |
Ejemplares similares
-
Risk factors for upper tract urothelial recurrence following local excision of bladder cancer
por: Lin, Ning, et al.
Publicado: (2018) -
Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression
por: Su, Hongwei, et al.
Publicado: (2019) -
Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage‐colony stimulating factor and interleukin‐2 surface modified MB49 bladder cancer stem cells vaccine
por: Wang, Chun‐yan, et al.
Publicado: (2017) -
Traditional Chinese Medicine CFF‐1 induced cell growth inhibition, autophagy, and apoptosis via inhibiting EGFR‐related pathways in prostate cancer
por: Wu, Zhaomeng, et al.
Publicado: (2018) -
Prognostic significance of bladder neck involvement in non‐muscle‐invasive bladder cancer: A SEER database analysis with 19,919 patients
por: Zhan, Xiangpeng, et al.
Publicado: (2021)